Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) announced plans to initiate a Health Canada-authorized Phase 3 clinical trial evaluating MDMA-assisted ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE